According to Lyell Immunopharma's latest financial reports the company's current EPS (TTM) is -$0.84. In 2022 the company made an earnings per share (EPS) of -$0.74 an increase over its 2021 EPS that were of -$2.24.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.84 | 13.51% |
2022 | -$0.74 | -66.99% |
2021 | -$2.24 | 128.13% |
2020 | -$0.98 |